Caroline Wolff-Ram

Caroline Wolff-Ram

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 122 publications

Durable remission after allogeneic transplantation despite residual blood disease in Sézary syndrome.

Durable remission after allogeneic transplantation despite residual blood disease in Sézary syndrome.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 05, 2026

Cutaneous T-cell lymphoma in the setting of NIPAL4-related nonsyndromic epidermal differentiation disorder: three cases.

Cutaneous T-cell lymphoma in the setting of NIPAL4-related nonsyndromic epidermal differentiation disorder: three cases.

Journal: The British journal of dermatology

Published: March 27, 2026

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome.

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome.

Journal: The British journal of dermatology

Published: March 13, 2026

Efficacy of anifrolumab in one patient with concomitant systemic lupus erythematosus and subcutaneous panniculitis-like T-cell lymphoma.

Efficacy of anifrolumab in one patient with concomitant systemic lupus erythematosus and subcutaneous panniculitis-like T-cell lymphoma.

Journal: Annales de dermatologie et de venereologie

Published: November 04, 2025

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 13, 2025

Clinical characteristics of mycosis fungoides with angiotropism.

Clinical characteristics of mycosis fungoides with angiotropism.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 17, 2025

Computational Free Flow Cytometry for Sézary Cells Identification and Quantification.

Computational Free Flow Cytometry for Sézary Cells Identification and Quantification.

Journal: The Journal of investigative dermatology

Published: January 29, 2025

Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.

Journal: EClinicalMedicine

Published: December 25, 2024

Comment on 'Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder' by Wobser et al.

Comment on 'Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder' by Wobser et al.

Journal: The British journal of dermatology

Published: October 28, 2024

Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients.

Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients.

Journal: Histopathology

Published: August 10, 2024

Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.

Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.

Journal: Journal of the American Academy of Dermatology

Published: July 17, 2024

Improving disease-specific survival for patients with Sezary syndrome in the modern era of systemic therapies.

Improving disease-specific survival for patients with Sezary syndrome in the modern era of systemic therapies.

Journal: British journal of haematology

Published: June 17, 2024

Showing 1-12 of 122

Last Updated: 09/26/2026